Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018

Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018–2020)

Published:2021-07-19 Issue:6 Volume:49 Page:1195-1202
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Yang Zhaojie,Yang Xuan,Deng Xin,Wei Shuguang,Liu Jinjin,Ma Jie,Zhao Qingxia,Huo Yuqi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s15010-021-01668-9.pdf

Reference31 articles.

1. World Health Organization. Joint United Nations Programme on HIV/AIDS (UNAIDS).https://www.unaids.org/en/resources/documents/2019/aids-by-the-numbers.

2. Michaels SH, Clark R, Kissinger P. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;339:405–6.

3. Winans S, Goff SP. Mutations altering acetylated residues in the CTD of HIV-1 integrase cause defects in proviral transcription at early times after integration of viral DNA. PLoS Pathog. 2020;16:e1009147.

4. Emery S, Winston A. Raltegravir: a new choice in HIV and new chances for research. Lancet (London, England). 2009;374:764–6.

5. Desimmie BA, Schrijvers R, Debyser Z. Elvitegravir: a once daily alternative to raltegravir. Lancet Infect Dis. 2012;12:3–5.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Full-Spectrum Surveillance of Pre-Treatment HIV Drug Resistance in Southeastern China;Pharmaceuticals;2024-07-06

2. A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World Settings;Viruses;2023-12-14

3. Prevalence and analysis of acquired and transmitted integrase strand transfer inhibitor-associated HIV-1 drug resistance in Chongqing, China;Virulence;2023-11-09

4. Increased prevalence of pretreatment drug resistance mutations in treatment-naïve people living with HIV-1 in Henan Province, China (2022/23);Infection, Genetics and Evolution;2023-11

5. Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China;Nature Communications;2023-09-02